AstraZeneca PLC
AstraZeneca PLC (AZN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AZN · as of Sep 30, 2024
Ownership Breakdown
1,271
Institutional Holders
▲ 26 vs Q2
$38.37B
Total Inst. Value
▼ $582.25M vs Q2
1.55B
Shares Outstanding
freeFloat 99.38%
492.09M
13F Shares Held
▼ 7.08M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AZN largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 62.89M | 4.05% | 4.05% | $4.90T | Nov 14, 2024 | ▼ 2.05M |
PRIMECAP MANAGEMENT CO/CA/ pharmaceutical preparations | 41.98M | 2.70% | 2.70% | $3.27T | Nov 8, 2024 | ▼ 617.2K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 37.25M | 2.40% | 2.40% | $2.90T | Nov 14, 2024 | ▼ 3.32M |
CAPITAL INTERNATIONAL INVESTORS pharmaceutical preparations | 36.82M | 2.37% | 2.37% | $2.87T | Nov 13, 2024 | ▲ 117.4K |
FMR LLC pharmaceutical preparations | 23.12M | 1.49% | 1.49% | $1.80T | Nov 13, 2024 | ▲ 258.5K |
FRANKLIN RESOURCES INC pharmaceutical preparations | 19.12M | 1.23% | 1.23% | $1.49T | Nov 27, 2024 | ▲ 1.52M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 17.57M | 1.13% | 1.13% | $1.37T | Mar 18, 2025 | ▲ 1.71M |
SANDERS CAPITAL, LLC pharmaceutical preparations | 14.97M | 96.36% | 96.36% | $1.17T | Nov 13, 2024 | ▲ 29.1K |
JENNISON ASSOCIATES LLC pharmaceutical preparations | 14.96M | 96.29% | 96.29% | $1.17T | Nov 8, 2024 | ▼ 2.06M |
MORGAN STANLEY pharmaceutical preparations | 12.82M | 82.53% | 82.53% | $999.19B | May 14, 2025 | ▲ 424.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
29
Increased
+14.62M shares1
New Positions
first time holders20
Decreased
−11.56M shares0
Sold Out
fully exitedNet shares change (top 50)
+3.06M
+14.62M / −11.56M
Net new holders
+10
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AZN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sharma Mani See Remarks | May 20, 2026 | Sale | 11,893 | $185.78 | $2.21M | 19.3K | Form 4 ↗ |
Sharma Mani See Remarks | May 6, 2026 | Award | 1 | $186.28 | $186.28 | 31.2K | Form 4 ↗ |
Sharma Mani See Remarks | Apr 7, 2026 | Award | 1 | $196.03 | $196.03 | 31.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
AstraZeneca PLC (AZN) is primarily owned by institutional investors, who hold approximately 31.7% of total shares outstanding. Company insiders own approximately 0.62%, while retail and public investors account for the remaining 67.65%.
The largest institutional shareholder of AstraZeneca PLC is PRICE T ROWE ASSOCIATES INC /MD/, holding approximately 62.89 million shares — equal to 4.05% of outstanding shares — as of September 30, 2024.
A total of 1,271 institutional investors currently hold AZN stock, with a combined institutional value of approximately $38.37 billion as of the most recent 13F filing period.
Frequently asked questions
AZN ownershipAstraZeneca PLC (AZN) is primarily owned by institutional investors, who hold approximately 31.7% of shares. The largest shareholder is PRICE T ROWE ASSOCIATES INC /MD/ with a 4.05% stake. Company insiders hold 0.62%. Data sourced from SEC Form 13F as of September 30, 2024.